News

Pathlight Capital Successfully Launches New Credit Funds with $1.9B

Pathlight Capital Successfully Launches New Credit Funds with $1.9B

Pathlight Capital Closes Two New Financing Funds

Pathlight Capital LP is excited to announce the successful closing of its fourth fund, known as Pathlight Capital Fund IV LP, alongside the second tranche of its Evergreen fund, referred to as Pathlight Capital Evergreen Fund LP. Together, these funds attracted an impressive $1.9 billion in capital commitments, showcasing a significant boost in Pathlight's investment capabilities.

Innovative Funding Structure

The recent fundraising introduced a new rated-note feeder structure, further expanding Pathlight's portfolio of financial solutions. With over $3.4 billion in assets under management, Pathlight now stands as a leader in providing asset-based financing solutions tailored to address various funding needs, including working capital, growth, acquisitions, and turnaround strategies.

A Diverse Investor Base Engages

The funds gathered support from a wide array of investors, including insurance companies, endowments, foundations, and public and corporate pension funds. Notably, there was a remarkable 100% re-up from the institutional limited partners from the predecessor fund, reflecting strong confidence in Pathlight's established approach.

CEO's Vision for Future Growth

Daniel Platt, the Founder and CEO of Pathlight, expressed his gratitude, stating, "The oversubscribed fundraise underscores the strong support for Pathlight's approach and the consistency of the platform we have built since inception. As private credit evolves, asset-based lending is becoming increasingly vital for businesses aiming to unlock value from their assets. We believe in our rigorous underwriting and deep experience in this area as essential elements of our success."

Investor Relations Approach

Managing Directors of Investor Relations, Stephanie Fatzinger and Laura Hegarty, added, "The demand throughout this process has been very encouraging, and we appreciate the confidence shown by both long-standing and new investors. The Evergreen vehicle alone surpassed one billion dollars in commitments, which speaks volumes about the appeal of flexible, long-term investment strategies."

Overall, the completion of this successful fundraising was a firm-wide effort, demonstrating Pathlight's commitment to delivering a top-notch experience for all investors involved.

Legal Advisory Support

Pathlight Capital enlisted the legal expertise of Kirkland & Ellis LLP in shaping the legal framework necessary for this ambitious endeavor. The dedicated efforts of partners Richard Shamos and Sean Hill in investment funds ensured that the firm was well-prepared to navigate the complexities of these new funds.

Understanding Pathlight's Offering

At its core, Pathlight provides asset-based loans that are secured on either a first or second lien basis against tangible and intangible assets. By offering creative financing solutions, the firm enables management teams to access essential liquidity for various purposes, including funding working capital, refinancing, growth initiatives, dividends, and strategic turnaround efforts.

Reasons to Partner with Pathlight

Businesses looking for tailored financial solutions can greatly benefit from Pathlight's expertise. With its commitment to understanding client needs and providing exceptional service, Pathlight stands out as a trusted partner in the world of asset-based lending.

Frequently Asked Questions

What types of financing solutions does Pathlight Capital offer?

Pathlight Capital specializes in asset-based loans, providing tailored financing solutions for working capital, growth, acquisitions, and turnaround strategies.

How much capital did Pathlight Capital raise in this recent closing?

Pathlight Capital successfully raised a total of $1.9 billion in capital commitments across its new funds.

Who are Pathlight's typical investors?

The investor base includes insurance companies, endowments, foundations, and corporate and public pension funds.

What is the importance of asset-based lending?

Asset-based lending helps businesses unlock the value of their assets, providing necessary liquidity for various strategic needs.

How does Pathlight plan to use the raised funds?

The raised funds will be utilized to support businesses in their working capital, growth initiatives, refinancing, and other acquisition-related activities.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

UEG's New Advisory Board: Elevating Patient Voices

Updated Category News Views 8

Breaking Ground with Patient Representation Today's not-so-sunny forecast from Barcelona wasn't about the weather. United European Gastroenterology (UEG) rolled out its shiny new Patient Representatives Advisory Board (PRAB) during UEG Week 2026. This isn't just another committee on a never-ending list—it's a serious platform aimed at turning patient murmurs into a...

Continue Reading
Antheia Secures $80M for Critical Medicine Onshoring

Updated Category News Views 10

Antheia's Bold Move to Onshore Medicine Production Folks, when it comes to pharmaceuticals, it's about time someone started serious about keeping things closer to home. Antheia just landed a huge $80 million conditional commitment from the U.S. Department of War's Office of Strategic Capital. The fine print? This isn't just about building business—it's a play to secure...

Continue Reading
Faith and Resilience in China: The Legacy of the Long March

Updated Category News Views 5

History's got chapters that stick with you, and the Long March is one of those stories that shake you to your core. It all started one October evening in 1934, when more than 86,000 soldiers from the Red Army found themselves on the banks of the Yudu River. It was a scene straight out of a novel: 800-odd boats held together with coffin boards and timber beams, all set to...

Continue Reading
Tomorrowland's Shanghai Return: An Electri-Lifesaver

Updated Category News Views 5

You know, every now and then, it's worth stepping out of the stock frenzy and diving into something as electrifying and far from the trading floor as Tomorrowland's latest Shanghai rendezvous. This ain't just any festival; it's the kind of hype that packs a punch—and frankly, it's a wild ride seeing such a spectacle set up shop in China, and sell out to boot. Partnering...

Continue Reading
AEVEX Faces 48-Hour Deadline for Investor Class Action

Updated Category News Views 4

Clock Ticking on AEVEX Lawsuit Participation Ah, the twists and turns of the stock market! AEVEX Corp. (NYSE: AVEX) finds itself knee-deep in a class action lawsuit, and investors have a mere 48 hours left to make their stand as the lead plaintiff. This legal saga stems from the company's April 2026 IPO and spills into the muddy waters of securities law violations....

Continue Reading
Lundbeck's Board Leadership Transitions into New Era

Updated Category News Views 4

A Fresh Chapter for Lundbeck's Board Leadership Lundbeck is sparking some fresh boardroom energy, and it's not just business as usual. Dorothea Wenzel, who's been steering the ship, is stepping down come 2027—AGM in sight. Now, in swings Lars Fruergaard Jørgensen, ready to grab the wheel. Yeah, we've got some seasoned pharma muscles flexing here. The Before and After:...

Continue Reading
ASTS Faces a Legal Countdown – Investors Take Note

Updated Category News Views 5

AST SpaceMobile's Legal Tangle AST SpaceMobile, Inc. (NASDAQ:ASTS) finds itself neck-deep in legal quagmire, with a class action lawsuit looming large. Investors who snapped up ASTS securities between March 4, 2025, and July 15, 2026, have until November 13, 2026, to reckon their grievances before the courts. This is no joke, folks. If you've lost dough because of shaky...

Continue Reading

Top 5 Most Recently Viewed Articles

Exploring the Rise and Fall of MedMen's Cannabis Empire

Updated Category News Views 178

Let's slice through the smoke and mirrors of MedMen's saga—a story that captures the dizzying heights and staggering lows of what was once the poster child for America's cannabis gold rush. The buzz is about a documentary from Bungalow Media + Entertainment that’s gearing up to pull back the curtain on Adam Bierman and his rollercoaster ride with MedMen. They kicked...

Continue Reading
Draganfly Secures $25 Million for Innovative Drone Solutions

Updated Category News Views 136

Overview of Recent Financial Activities Draganfly Inc. (NASDAQ: DPRO), a leader in drone technology and robotics, has made significant strides in its financial landscape by securing a registered direct offering. This initiative is designed to enhance their operational capabilities and support new product developments. Details of the Direct Offering In a recent...

Continue Reading
Current Sentiment Analysis: Canaan Inc's Short Interest Insights

Updated Category News Views 304

Canaan Inc's Current Short Interest Overview Canaan Inc (NYSE: CAN) is witnessing changes in its stock sentiment, particularly regarding its short interest. Recent reports indicate that the short interest, expressed as a percentage of the float, has dropped by 8.14%. Currently, 36.17 million shares are sold short, representing 8.58% of the total shares available for...

Continue Reading
iHerb's Chief Operating Officer Miriee Chang Set to Retire

Updated Category News Views 196

iHerb Announces Retirement of COO Miriee Chang iHerb, a global leader in online retail for wellness products, has announced the planned retirement of Chief Operating Officer Miriee Chang. This change marks a significant transition for the company, dedicated to maintaining its operational excellence and customer service quality. Continuity During the Transition Miriee...

Continue Reading
Liberty Broadband to Reveal Q4 2024 Performance in Upcoming Call

Updated Category News Views 103

Liberty Broadband Corporation's Upcoming Conference Call Liberty Broadband Corporation (Nasdaq: LBRDA, LBRDK, LBRDP) is gearing up for a significant event as it prepares to hold a conference call to unveil its financial results for the fourth quarter of 2024. This highly anticipated call is set to take place soon, providing an opportunity for stakeholders and interested...

Continue Reading